‚ÄúSerious adverse event‚ÄĚ in AstraZeneca‚Äôs COVID-19 vaccine trial revealed as spinal inflammation disorder caused by toxic adjuvants

It has finally¬†been revealed¬†that the participant in AstraZeneca‚Äôs Wuhan coronavirus (COVID-19) vaccine trial who suffered a ‚Äúserious adverse event,‚ÄĚ causing a global shutdown of the company‚Äôs entire phase-three trial, developed a spinal inflammatory disorder known as transverse myelitis. Company CEO Pascal Soriot told JP Morgan and other investors over a conference call that the woman... Continue Reading →

Create a website or blog at WordPress.com

Up ↑